Continue to Site »
Site will load in 15 seconds

NIHC Makes Policy Statement on Delta-8 THC

NIHC: “The safety profile of delta-8 THC products is questionable.”

D8 Thc Adobe Stock457044315736
Adobe Stock

Tony Headshot

WASHINGTON, Sept. 30, 2021 – PRESS RELEASE – Last week, the National Industrial Hemp Council (NIHC) met with more than 20 state regulators at the National Association of State Departments of Agriculture (NASDA) conference on what is working and not working in their state hemp programs. NIHC officials repeatedly heard their deep concerns about the impact of delta-8 THC on public health and the need to revise the federal definition of hemp.

Advertisment: Cannabis Business Times » Cannabis Business Times Best Cannabis Companies to Work For » CBT Best Companies 2026 ROS Parallax Reveal » bcc-ads-730x570
Advertisment: Cannabis Business Times » Cannabis Business Times Best Cannabis Companies to Work For » CBT Best Companies 2026 ROS Parallax Reveal » bcc-ads-730x570

In light of those meetings, and after statements of similar concerns recently made by the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC), NIHC issued its position on delta-8:

Advertisment: Hydrofarm » Hydrofarm Order 113 » CBT ROS 300x250 Medium Rectangle » PhotoBio MX2 Med Rectangle Ad

"NIHC continues to believe that consumer safety is paramount for all products in the hemp market. The safety profile of delta-8 THC products is questionable, and we believe that they should not be sold or marketed as hemp-derived products.

Advertisment: Hydrofarm » Hydrofarm Order 113 » CBT ROS 300x250 Medium Rectangle » PhotoBio MX2 Med Rectangle Ad

"The clearest pathway to protect consumer safety and create a hemp economy that works for everyone is to revise the federal definition of hemp to include all tetrahydrocannabinols, as recommended by NASDA with the bipartisan support of 45 states, and as broadly supported by stakeholders throughout the industry, regulatory officials, and in both chambers and parties on Capitol Hill.  Such a clarification in statute would unequivocally prevent the sale of products containing unsafe concentrations of delta-8 THC as hemp.

"Delta-8 THC has flooded the market because of the lack of regulatory certainty from the FDA on cannabidiol and other hemp-derived products. Along with Congress changing the statutory definition of hemp to 1 percent total THC, the FDA can do its part to protect consumer safety by making clear guidelines for hemp-derived products as Congress intended in the 2018 Farm Bill."

NIHC Government Affairs Committee members continue to have conversations and look at more intricate policy solutions on delta-8. The committee will release more details in the coming weeks. In the meantime, the mid-November Hemp Business Summit in Washington, D.C., offers opportunities for NIHC members, industry stakeholders and regulators to actively engage with one another in person on how to regulate delta-8.

Advertisment: Hydrofarm » Hydrofarm Order 113 » CBT ROS 300x250 Medium Rectangle » PhotoBio MX2 Med Rectangle Ad
Advertisment: Hanwha Vision » Hanwha Vision Order 78 » CBT ROS 300x250 Medium Rectangle June 2025 » Hanwha January Ad
Page 1 of 127
Next Page
Advertisment: Greentank » Greentank Order 92 » CBT ROS Mobile Adhesion 360x120 June 2025 » cbt-mobile-gt-shop